Our study sought to describe ocular surface alterations at baseline and after 4 months of dupilumab treatment in patients with severe AD. Our findings highlight that all 25 patients showed ocular surface alterations prior to dupilumab treatment. Dupilumab may cause the worsening of clinical or subclinical pre-existing ocular alterations belonging to the spectrum of AKC.

New insights on ocular surface disease in patients with atopic dermatitis treated with dupilumab / P. Bortoluzzi, S. Ferrucci, D. Galimberti, F. Garavelli, F. Pozzo Giuffrida, A. Pizzati, A.V. Marzano, C. Mapelli. - In: BRITISH JOURNAL OF DERMATOLOGY. - ISSN 1365-2133. - (2021), pp. 1-3. [Epub ahead of print] [10.1111/bjd.20706]

New insights on ocular surface disease in patients with atopic dermatitis treated with dupilumab

P. Bortoluzzi
Primo
;
D. Galimberti;F. Garavelli;F. Pozzo Giuffrida;A. Pizzati;A.V. Marzano
Penultimo
;
C. Mapelli
2021

Abstract

Our study sought to describe ocular surface alterations at baseline and after 4 months of dupilumab treatment in patients with severe AD. Our findings highlight that all 25 patients showed ocular surface alterations prior to dupilumab treatment. Dupilumab may cause the worsening of clinical or subclinical pre-existing ocular alterations belonging to the spectrum of AKC.
Settore MED/35 - Malattie Cutanee e Veneree
25-ago-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
bjd.20706.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.08 MB
Formato Adobe PDF
1.08 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/886064
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 2
social impact